{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:00:49Z","timestamp":1787032849751,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,6]]},"DOI":"10.7759\/cureus.110353","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T14:07:51Z","timestamp":1780754871000},"source":"Crossref","is-referenced-by-count":1,"title":["Severe Hypoprothrombinemia Associated With Vitamin K Deficiency During Prolonged Cefazolin Therapy in a Hemodialysis Patient"],"prefix":"10.7759","author":[{"given":"Mari","family":"Morimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Mihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munehiro","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuto","family":"Sunahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nariko","family":"Ikemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayo","family":"Kitamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Kusaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Hamashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Yuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Tamagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.08.046","article-title":"Vitamin K in parenteral nutrition","volume":"137","author":"Shearer MJ","year":"2009","unstructured":"Shearer MJ. Vitamin K in parenteral nutrition. Gastroenterology. 2009, 137:S105-18. 10.1053\/j.gastro.2009.08.046","journal-title":"Gastroenterology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp070243","article-title":"Cefazolin-induced hypoprothrombinemia","volume":"65","author":"Chung AH","year":"2008","unstructured":"Chung AH, Watson K. Cefazolin-induced hypoprothrombinemia. Am J Health Syst Pharm. 2008, 65:823-6. 10.2146\/ajhp070243","journal-title":"Am J Health Syst Pharm"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/nu11010168","article-title":"Vitamin K in chronic kidney disease","volume":"11","author":"Cozzolino M","year":"2019","unstructured":"Cozzolino M, Mangano M, Galassi A, Ciceri P, Messa P, Nigwekar S. Vitamin K in chronic kidney disease. Nutrients. 2019, 11:10.3390\/nu11010168","journal-title":"Nutrients"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s41038-019-0150-7","article-title":"Hypocoagulation induced by broad-spectrum antibiotics in extensive burn patients","volume":"7","author":"Liu J","year":"2019","unstructured":"Liu J, Liu Y, Liu S, Zhang Q, Zheng J, Niu Y, Wang X. Hypocoagulation induced by broad-spectrum antibiotics in extensive burn patients. Burns Trauma. 2019, 7:13. 10.1186\/s41038-019-0150-7","journal-title":"Burns Trauma"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0083-6729(07)00007-6","article-title":"Vitamin K-dependent carboxylation","volume":"78","author":"Berkner KL","year":"2008","unstructured":"Berkner KL. Vitamin K-dependent carboxylation. Vitam Horm. 2008, 78:131-56. 10.1016\/S0083-6729(07)00007-6","journal-title":"Vitam Horm"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/00075197-200011000-00004","article-title":"Role of vitamin K and Gla proteins in the pathophysiology of osteoporosis and vascular calcification","volume":"3","author":"Shearer MJ","year":"2000","unstructured":"Shearer MJ. Role of vitamin K and Gla proteins in the pathophysiology of osteoporosis and vascular calcification. Curr Opin Clin Nutr Metab Care. 2000, 3:433-8. 10.1097\/00075197-200011000-00004","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-024-05001-2","article-title":"Vitamin K: a potential missing link in critical illness-a scoping review","volume":"28","author":"Paulus MC","year":"2024","unstructured":"Paulus MC, Drent M, Kouw IW, Balvers MG, Bast A, van Zanten AR. Vitamin K: a potential missing link in critical illness-a scoping review. Crit Care. 2024, 28:212. 10.1186\/s13054-024-05001-2","journal-title":"Crit Care"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1021\/bi700527j","article-title":"The conversion of vitamin K epoxide to vitamin K quinone and vitamin K quinone to vitamin K hydroquinone uses the same active site cysteines","volume":"46","author":"Jin DY","year":"2007","unstructured":"Jin DY, Tie JK, Stafford DW. The conversion of vitamin K epoxide to vitamin K quinone and vitamin K quinone to vitamin K hydroquinone uses the same active site cysteines. Biochemistry. 2007, 46:7279-83. 10.1021\/bi700527j","journal-title":"Biochemistry"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/foods10123136","article-title":"Relationship between structure and biological activity of various vitamin K forms","volume":"10","author":"Bus K","year":"2021","unstructured":"Bus K, Szterk A. Relationship between structure and biological activity of various vitamin K forms. Foods. 2021, 10:10.3390\/foods10123136","journal-title":"Foods"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/idr13010021","article-title":"Deranged coagulation profile secondary to cefazolin use: Case report","volume":"13","author":"Ngiam JN","year":"2021","unstructured":"Ngiam JN, Liong TS, Tham SM, et al.. Deranged coagulation profile secondary to cefazolin use: Case report. Infect Dis Rep. 2021, 13:187-90. 10.3390\/idr13010021","journal-title":"Infect Dis Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/18.6.772","article-title":"Hypoprothrombinaemia and bleeding associated with cefazolin","volume":"18","author":"Kurz RW","year":"1986","unstructured":"Kurz RW, Wallner M, Graninger W, Tragl RH. Hypoprothrombinaemia and bleeding associated with cefazolin. J Antimicrob Chemother. 1986, 18:772-3. 10.1093\/jac\/18.6.772","journal-title":"J Antimicrob Chemother"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3945\/jn.111.154807","article-title":"Age group and sex do not influence responses of vitamin K biomarkers to changes in dietary vitamin K","volume":"142","author":"Truong JT","year":"2012","unstructured":"Truong JT, Fu X, Saltzman E, Al Rajabi A, Dallal GE, Gundberg CM, Booth SL. Age group and sex do not influence responses of vitamin K biomarkers to changes in dietary vitamin K. J Nutr. 2012, 142:936-41. 10.3945\/jn.111.154807","journal-title":"J Nutr"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/nu12092513","article-title":"Causes of vitamin K deficiency in patients on haemodialysis","volume":"12","author":"Wikstr\u00f8m S","year":"2020","unstructured":"Wikstr\u00f8m S, Aagaard Lentz K, Hansen D, Melholt Rasmussen L, Jakobsen J, Post Hansen H, Andersen JR. Causes of vitamin K deficiency in patients on haemodialysis. Nutrients. 2020, 12:10.3390\/nu12092513","journal-title":"Nutrients"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1988.tb03106.x","article-title":"Mechanism of cephalosporin-induced hypoprothrombinemia: relation to cephalosporin side chain, vitamin K metabolism, and vitamin K status","volume":"28","author":"Shearer MJ","year":"1988","unstructured":"Shearer MJ, Bechtold H, Andrassy K, et al.. Mechanism of cephalosporin-induced hypoprothrombinemia: relation to cephalosporin side chain, vitamin K metabolism, and vitamin K status. J Clin Pharmacol. 1988, 28:88-95. 10.1002\/j.1552-4604.1988.tb03106.x","journal-title":"J Clin Pharmacol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.31.2.281","article-title":"Coagulopathy associated with extended-spectrum cephalosporins in patients with serious infections","volume":"31","author":"Nichols RL","year":"1987","unstructured":"Nichols RL, Wikler MA, McDevitt JT, Lentnek AL, Hosutt JA. Coagulopathy associated with extended-spectrum cephalosporins in patients with serious infections. Antimicrob Agents Chemother. 1987, 31:281-5. 10.1128\/AAC.31.2.281","journal-title":"Antimicrob Agents Chemother"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.accpm.2017.07.006","article-title":"Hypoprothrombinemia and severe perioperative haemorrhagic complications in cardiac surgery patients treated with high-dose cefazolin for infective endocarditis","volume":"37","author":"Angles E","year":"2018","unstructured":"Angles E, Mouton C, Perino J, Remy A, Ouattara A. Hypoprothrombinemia and severe perioperative haemorrhagic complications in cardiac surgery patients treated with high-dose cefazolin for infective endocarditis. Anaesth Crit Care Pain Med. 2018, 37:167-70. 10.1016\/j.accpm.2017.07.006","journal-title":"Anaesth Crit Care Pain Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/1060028014537038","article-title":"Necrotizing esophagitis and bleeding associated with cefazolin","volume":"48","author":"Barnes T","year":"2014","unstructured":"Barnes T, Yan S, Kaakeh Y. Necrotizing esophagitis and bleeding associated with cefazolin. Ann Pharmacother. 2014, 48:1214-8. 10.1177\/1060028014537038","journal-title":"Ann Pharmacother"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2022.2095859","article-title":"Cefazolin-induced hypoprothrombinemia","volume":"35","author":"Smith M","year":"2022","unstructured":"Smith M, Doyle J, Crane C, Bussell C. Cefazolin-induced hypoprothrombinemia. Proc (Bayl Univ Med Cent). 2022, 35:868-70. 10.1080\/08998280.2022.2095859","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2023000502","article-title":"Consumptive coagulopathy in the ICU","volume":"2023","author":"Retter A","year":"2023","unstructured":"Retter A, Hunt BJ. Consumptive coagulopathy in the ICU. Hematology Am Soc Hematol Educ Program. 2023, 2023:754-60. 10.1182\/hematology.2023000502","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aei169","article-title":"Coagulopathy and blood component transfusion in trauma","volume":"95","author":"Spahn DR","year":"2005","unstructured":"Spahn DR, Rossaint R. Coagulopathy and blood component transfusion in trauma. Br J Anaesth. 2005, 95:130-9. 10.1093\/bja\/aei169","journal-title":"Br J Anaesth"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/486854-severe-hypoprothrombinemia-associated-with-vitamin-k-deficiency-during-prolonged-cefazolin-therapy-in-a-hemodialysis-patient","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T14:07:52Z","timestamp":1780754872000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/486854-severe-hypoprothrombinemia-associated-with-vitamin-k-deficiency-during-prolonged-cefazolin-therapy-in-a-hemodialysis-patient"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.110353","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,6]]}}}